South Asian Heart Ctr-El Camino Hospital

Ancora Heart Inc, based in Santa Clara, CA, is dedicated to addressing the challenges faced by individuals battling heart failure, a leading cause of mortality in modern times. The company focuses on the development of AccuCinch®, an innovative therapy designed to expand treatment options for patients grappling with heart failure, also known as congestive heart failure (CHF). The AccuCinch Ventricular Restoration System, designated as a Breakthrough Device by the FDA, aims to enhance the quality of life for individuals experiencing common heart failure symptoms such as fatigue, breathing difficulties, and memory issues. By leveraging early feasibility clinical data, Ancora Heart aims to showcase the positive impact of the AccuCinch System on patients' quality of life, functional capacity, and potential for reverse remodeling, specifically for those with heart failure and reduced ejection fraction (HFrEF). By enrolling patients in the CORCINCH-HF Study, a randomized, controlled clinical trial, Ancora Heart is actively pursuing further evidence of the AccuCinch System's benefits for heart failure patients. Committed to innovation and teamwork, Ancora Heart strives to build upon decades of expertise to provide relief and comfort for individuals struggling with heart failure. Generated from the website content

HeartFlow, Inc., based in Mountain View, CA, is dedicated to transforming coronary artery disease (CAD) from a major health threat into a manageable condition through innovative technologies. Their pioneering AI analysis creates detailed 3D models of the heart, enabling personalized treatment pathways for patients and enhancing the accuracy of diagnostics beyond traditional methods. With a commitment to improving patient outcomes, HeartFlow's platform incorporates advanced functions like FFRCT Analysis and Plaque Analysis, which support healthcare providers in making informed decisions on treatment plans. The company has successfully treated over 400,000 patients and is rapidly expanding its presence in institutions worldwide, backed by a robust foundation of clinical evidence and research. Generated from the website

The Center for Inherited Cardiovascular Disease Program provides comprehensive care to patients with inherited heart disease. Our multi-disciplinary team ensures thorough evaluations, personalized recommendations, and support for everyone in your family.